Pfizer’s Started Clinical Trials For Its Covid Antiviral In Kids
ForbesAPR 2022
It's important for drug companies to work on COVID treatments for children, as vaccination has been shown to be less effective for preventing urgent care visits and hospitalizations for kids than teenagers.
Vaccination remains the best protection for everyone, including children, against COVID infection. These treatments might not be available for a while and we should be encouraging vaccination.
Pfizer, which made $37 billion from vaccine sales in 2021, is profiting off the pandemic. The sale of treatments, in addition to shots, will only increase their earnings in 2022. We ought to focus first on making treatments and vaccinations more affordable and accessible around the world.